KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Thermo Fisher Scientific (TMO) Accumulated Depreciation & Amortization (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $6.1 billion as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Accumulated Depreciation & Amortization rose 21.79% year-over-year to $6.1 billion, compared with a TTM value of $6.1 billion through Dec 2023, up 21.79%, and an annual FY2023 reading of $6.1 billion, up 21.79% over the prior year.
  • Accumulated Depreciation & Amortization was $6.1 billion for Q4 2023 at Thermo Fisher Scientific, up from $5.0 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $6.1 billion in Q4 2023 and bottomed at $3.0 billion in Q4 2019.
  • Average Accumulated Depreciation & Amortization over 5 years is $4.4 billion, with a median of $4.3 billion recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 33.0% in 2019, then grew 16.23% in 2021.
  • Year by year, Accumulated Depreciation & Amortization stood at $3.0 billion in 2019, then grew by 21.56% to $3.7 billion in 2020, then increased by 16.23% to $4.3 billion in 2021, then increased by 17.11% to $5.0 billion in 2022, then grew by 21.79% to $6.1 billion in 2023.
  • Business Quant data shows Accumulated Depreciation & Amortization for TMO at $6.1 billion in Q4 2023, $5.0 billion in Q4 2022, and $4.3 billion in Q4 2021.